Skip to main content

Orion Corporation’s financial reporting and Annual General Meeting in 2027

Written by Customer Service on . Posted in Public Companies.

ORION CORPORATION 
STOCK EXCHANGE RELEASE – FINANCIAL CALENDAR
17 JULY 2026 at 10.30 EEST
        

Orion Corporation’s financial reporting and Annual General Meeting in 2027

Orion Corporation will publish its Financial Statement Release 2026 on Wednesday, 17 February 2027. The Financial Statements and the Report by the Board of Directors for 2026 will be published at the latest in week 9/2027.

The publication dates of the Interim Reports and the Half-Year Financial Report in 2027 are as follows:

Interim Report January-March 2027Thursday 22 April 2027
Half-Year Financial Report January-June 2027Tuesday 20 July 2027
Interim Report January-September 2027Wednesday 27 October 2027

Orion’s financial reports will be published at approximately 8.30 am Finnish time.

The Annual General Meeting is planned to be held on Tuesday, 23 March 2027.

Financial reports and related presentation material are available at http://www.orionpharma.com/investors promptly after the publishing. The website also provides a possibility to register on Orion’s mailing lists for releases.

Orion Corporation

Liisa Hurme

President and CEO

   Mikko Kemppainen

General Counsel

 

Contact person:
Tuukka Hirvonen, Head of Investor Relations

tel. +358 10 426 2721

                                                 

Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
http://www.orionpharma.com

Orion Pharma is a globally operating Nordic pharmaceutical company – a builder of well-being for over a hundred years. We develop, manufacture and market human and veterinary pharmaceuticals as well as active pharmaceutical ingredients, combining our trusted expertise with continuous innovation. We have an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by us are used to treat cancer, respiratory diseases and neurological diseases, among others. In 2025 our net sales amounted to EUR 1,890 million, and we employ about 4,000 professionals worldwide, dedicated to building well-being.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.